{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:23:42Z","timestamp":1794443022026,"version":"4.9.1"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T00:00:00Z","timestamp":1597708800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SFB 1181\/2-B02"],"award-info":[{"award-number":["SFB 1181\/2-B02"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2020,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>ITK (IL-2-inducible tyrosine kinase) belongs to the Tec family kinases and is mainly expressed in T cells. It is involved in TCR signalling events driving processes like T cell development as well as Th2, Th9 and Th17 responses thereby controlling the expression of pro-inflammatory cytokines. Studies have shown that ITK is involved in the pathogenesis of autoimmune diseases as well as in carcinogenesis. The loss of ITK or its activity either by mutation or by the use of inhibitors led to a beneficial outcome in experimental models of asthma, inflammatory bowel disease and multiple sclerosis among others. In humans, biallelic mutations in the ITK gene locus result in a monogenetic disorder leading to T cell dysfunction; in consequence, mainly EBV infections can lead to severe immune dysregulation evident by lymphoproliferation, lymphoma and hemophagocytic lymphohistiocytosis. Furthermore, patients who suffer from angioimmunoblastic T cell lymphoma have been found to express significantly more ITK. These findings put ITK in the strong focus as a target for drug development.<\/jats:p>","DOI":"10.1007\/s00109-020-01958-z","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T02:02:54Z","timestamp":1597716174000},"page":"1385-1395","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["Role of the IL-2 inducible tyrosine kinase ITK and its inhibitors in disease pathogenesis"],"prefix":"10.1007","volume":"98","author":[{"given":"Kristina S.","family":"Lechner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus F.","family":"Neurath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2398-0844","authenticated-orcid":false,"given":"Benno","family":"Weigmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"issue":"23","key":"1958_CR1","doi-asserted-by":"crossref","first-page":"11194","DOI":"10.1073\/pnas.89.23.11194","volume":"89","author":"JD Siliciano","year":"1992","unstructured":"Siliciano JD, Morrow TA, Desiderio SV (1992) Itk, a T-cell-specific tyrosine kinase gene inducible by interleukin 2. Proc Natl Acad Sci U S A 89(23):11194\u201311198","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"1958_CR2","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1182\/blood.V82.5.1561.1561","volume":"82","author":"S Gibson","year":"1993","unstructured":"Gibson S, Leung B, Squire JA, Hill M, Arima N, Goss P, Hogg D, Mills GB (1993) Identification, cloning, and characterization of a novel human T-cell-specific tyrosine kinase located at the hematopoietin complex on chromosome 5q. Blood 82(5):1561\u20131572","journal-title":"Blood"},{"issue":"2","key":"1958_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1073\/pnas.90.2.669","volume":"90","author":"SD Heyeck","year":"1993","unstructured":"Heyeck SD, Berg LJ (1993) Developmental regulation of a murine T-cell-specific tyrosine kinase gene, Tsk. Proc Natl Acad Sci U S A 90(2):669\u2013673","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1958_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-5793(93)81520-A","volume":"324","author":"N Tanaka","year":"1993","unstructured":"Tanaka N, Asao H, Ohtani K, Nakamura M, Sugamura K (1993) A novel human tyrosine kinase gene inducible in T cells by interleukin 2. FEBS Lett 324(1):1\u20135","journal-title":"FEBS Lett"},{"issue":"1","key":"1958_CR5","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/bbrc.1993.1404","volume":"192","author":"N Yamada","year":"1993","unstructured":"Yamada N, Kawakami Y, Kimura H, Fukamachi H, Baier G, Altman A, Kato T, Inagaki Y, Kawakami T (1993) Structure and expression of novel protein-tyrosine kinases, Emb and Emt, in hematopoietic cells. Biochem Biophys Res Commun 192(1):231\u2013240","journal-title":"Biochem Biophys Res Commun"},{"key":"1958_CR6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.immunol.22.012703.104743","volume":"23","author":"LJ Berg","year":"2005","unstructured":"Berg LJ, Finkelstein LD, Lucas JA, Schwartzberg PL (2005) Tec family kinases in T lymphocyte development and function. Annu Rev Immunol 23:549\u2013600","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1958_CR7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0092-8674(93)90667-F","volume":"72","author":"S Tsukada","year":"1993","unstructured":"Tsukada S, Saffran DC, Rawlings DJ, Parolini O, Allen RC, Klisak I, Sparkes RS, Kubagawa H, Mohandas T, Quan S, Belmont JW, Cooper MD, Conley ME, Witte ON (1993) Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia. Cell 72(2):279\u2013290","journal-title":"Cell"},{"issue":"12","key":"1958_CR8","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1111\/j.1742-4658.2011.08072.x","volume":"278","author":"J Gomez-Rodriguez","year":"2011","unstructured":"Gomez-Rodriguez J, Kraus ZJ, Schwartzberg PL (2011) Tec family kinases Itk and Rlk \/ Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates. FEBS J 278(12):1980\u20131989","journal-title":"FEBS J"},{"issue":"7","key":"1958_CR9","doi-asserted-by":"crossref","first-page":"a002287","DOI":"10.1101\/cshperspect.a002287","volume":"2","author":"AH Andreotti","year":"2010","unstructured":"Andreotti AH, Schwartzberg PL, Joseph RE, Berg LJ (2010) T-cell signaling regulated by the Tec family kinase, Itk. Cold Spring Harb Perspect Biol 2(7):a002287","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"6","key":"1958_CR10","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.178.6.3575","volume":"178","author":"D Khurana","year":"2007","unstructured":"Khurana D, Arneson LN, Schoon RA, Dick CJ, Leibson PJ (2007) Differential regulation of human NK cell-mediated cytotoxicity by the tyrosine kinase Itk. J Immunol 178(6):3575\u20133582","journal-title":"J Immunol"},{"issue":"5","key":"1958_CR11","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.4049\/jimmunol.180.5.3007","volume":"180","author":"M Felices","year":"2008","unstructured":"Felices M, Berg LJ (2008) The Tec kinases Itk and Rlk regulate NKT cell maturation, cytokine production, and survival. J Immunol 180(5):3007\u20133018","journal-title":"J Immunol"},{"issue":"5826","key":"1958_CR12","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1126\/science.1138684","volume":"316","author":"YH Huang","year":"2007","unstructured":"Huang YH, Grasis JA, Miller AT, Xu R, Soonthornvacharin S, Andreotti AH, Tsoukas CD, Cooke MP, Sauer K (2007) Positive regulation of Itk PH domain function by soluble IP4. Science 316(5826):886\u2013889","journal-title":"Science"},{"issue":"21","key":"1958_CR13","doi-asserted-by":"crossref","first-page":"11227","DOI":"10.1073\/pnas.94.21.11227","volume":"94","author":"A August","year":"1997","unstructured":"August A, Sadra A, Dupont B, Hanafusa H (1997) Src-induced activation of inducible T cell kinase (ITK) requires phosphatidylinositol 3-kinase activity and the Pleckstrin homology domain of inducible T cell kinase. Proc Natl Acad Sci U S A 94(21):11227\u201311232","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1958_CR14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4049\/jimmunol.165.1.256","volume":"165","author":"KA Ching","year":"2000","unstructured":"Ching KA, Grasis JA, Tailor P, Kawakami Y, Kawakami T, Tsoukas CD (2000) TCR\/CD3-induced activation and binding of Emt\/Itk to linker of activated T cell complexes: requirement for the Src homology 2 domain. J Immunol 165(1):256\u2013262","journal-title":"J Immunol"},{"issue":"2","key":"1958_CR15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1570-9639(02)00524-1","volume":"1645","author":"BF Nore","year":"2003","unstructured":"Nore BF, Mattsson PT, Antonsson P, B\u00e4ckesj\u00f6 CM, Westlund A, Lennartsson J, Hansson H, L\u00f6w P, R\u00f6nnstrand L, Smith CIE (2003) Identification of phosphorylation sites within the SH3 domains of Tec family tyrosine kinases. Biochim Biophys Acta 1645(2):123\u2013132","journal-title":"Biochim Biophys Acta"},{"issue":"41","key":"1958_CR16","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1074\/jbc.271.41.25646","volume":"271","author":"SC Bunnell","year":"1996","unstructured":"Bunnell SC, Henry PA, Kolluri R, Kirchhausen T, Rickles RJ, Berg LJ (1996) Identification of Itk\/Tsk Src homology 3 domain ligands. J Biol Chem 271(41):25646\u201325656","journal-title":"J Biol Chem"},{"issue":"12","key":"1958_CR17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S0962-8924(01)02154-7","volume":"11","author":"T Pawson","year":"2001","unstructured":"Pawson T, Gish GD, Nash P (2001) SH2 domains, interaction modules and cellular wiring. Trends Cell Biol 11(12):504\u2013511","journal-title":"Trends Cell Biol"},{"key":"1958_CR18","doi-asserted-by":"crossref","first-page":"10857","DOI":"10.1038\/ncomms10857","volume":"7","author":"J Gomez-Rodriguez","year":"2016","unstructured":"Gomez-Rodriguez J, Meylan F, Handon R, Hayes ET, Anderson SM, Kirby MR, Siegel RM, Schwartzberg PL (2016) Itk is required for Th9 differentiation via TCR-mediated induction of IL-2 and IRF4. Nat Commun 7:10857","journal-title":"Nat Commun"},{"issue":"4","key":"1958_CR19","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1074-7613(00)80115-6","volume":"11","author":"DJ Fowell","year":"1999","unstructured":"Fowell DJ, Shinkai K, Liao XC, Beebe AM, Coffman RL, Littman DR, Locksley RM (1999) Impaired NFATc translocation and failure of Th2 development in Itk-deficient CD4+ T cells. Immunity 11(4):399\u2013409","journal-title":"Immunity"},{"issue":"12","key":"1958_CR20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1038\/ni734","volume":"2","author":"EM Schaeffer","year":"2001","unstructured":"Schaeffer EM, Yap GS, Lewis CM, Czar MJ, McVicar DW, Cheever AW, Sher A, Schwartzberg PL (2001) Mutation of Tec family kinases alters T helper cell differentiation. Nat Immunol 2(12):1183\u20131188","journal-title":"Nat Immunol"},{"issue":"1","key":"1958_CR21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.immuni.2004.06.009","volume":"21","author":"AT Miller","year":"2004","unstructured":"Miller AT, Wilcox HM, Lai Z, Berg LJ (2004) Signaling through Itk promotes T helper 2 differentiation via negative regulation of T-bet. Immunity 21(1):67\u201380","journal-title":"Immunity"},{"issue":"4","key":"1958_CR22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.immuni.2009.07.009","volume":"31","author":"J Gomez-Rodriguez","year":"2009","unstructured":"Gomez-Rodriguez J, Sahu N, Handon R, Davidson TS, Anderson SM, Kirby MR, August A, Schwartzberg PL (2009) Differential expression of interleukin-17A and -17F is coupled to T cell receptor signaling via inducible T cell kinase. Immunity 31(4):587\u2013597","journal-title":"Immunity"},{"issue":"3","key":"1958_CR23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1084\/jem.20131459","volume":"211","author":"J Gomez-Rodriguez","year":"2014","unstructured":"Gomez-Rodriguez J, Wohlfert EA, Handon R, Meylan F, Wu JZ, Anderson SM, Kirby MR, Belkaid Y, Schwartzberg PL (2014) Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells. J Exp Med 211(3):529\u2013543","journal-title":"J Exp Med"},{"issue":"5","key":"1958_CR24","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.1400968","volume":"193","author":"W Huang","year":"2014","unstructured":"Huang W, Jeong AR, Kannan AK, Huang L, August A (2014) IL-2-inducible T cell kinase tunes T regulatory cell development and is required for suppressive function. J Immunol 193(5):2267\u20132272","journal-title":"J Immunol"},{"issue":"6","key":"1958_CR25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","volume":"19","author":"N Gagliani","year":"2013","unstructured":"Gagliani N, Magnani CF, Huber S, Gianolini ME, Pala M, Licona-Limon P, Guo B, Herbert D'BR, Bulfone A, Trentini F, di Serio C, Bacchetta R, Andreani M, Brockmann L, Gregori S, Flavell RA, Roncarolo MG (2013) Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells. Nat Med 19(6):739\u2013746","journal-title":"Nat Med"},{"issue":"4","key":"1958_CR26","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.immuni.2011.01.020","volume":"34","author":"S Huber","year":"2011","unstructured":"Huber S, Gagliani N, Esplugues E, O'Connor W Jr, Huber FJ, Chaudhry A, Kamanaka M, Kobayashi Y, Booth CJ, Rudensky AY, Roncarolo MG, Battaglia M, Flavell RA (2011) Th17 cells express interleukin-10 receptor and are controlled by Foxp3(\u2212) and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. Immunity 34(4):554\u2013565","journal-title":"Immunity"},{"key":"1958_CR27","doi-asserted-by":"crossref","first-page":"15871","DOI":"10.1038\/ncomms15871","volume":"8","author":"W Huang","year":"2017","unstructured":"Huang W, Solouki S, Koylass N, Zheng SG, August A (2017) ITK signalling via the Ras\/IRF4 pathway regulates the development and function of Tr1 cells. Nat Commun 8:15871","journal-title":"Nat Commun"},{"issue":"1","key":"1958_CR28","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/s41467-019-08699-9","volume":"10","author":"HS Cho","year":"2019","unstructured":"Cho HS, Reboldi A, Hall JA, Berg LJ (2019) The Tec kinase ITK is essential for ILC2 survival and epithelial integrity in the intestine. Nat Commun 10(1):784","journal-title":"Nat Commun"},{"issue":"5414","key":"1958_CR29","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1126\/science.284.5414.638","volume":"284","author":"EM Schaeffer","year":"1999","unstructured":"Schaeffer EM, Debnath J, Yap G et al (1999) Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunity. Science 284(5414):638\u2013641","journal-title":"Science"},{"issue":"10","key":"1958_CR30","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1084\/jem.187.10.1721","volume":"187","author":"KQ Liu","year":"1998","unstructured":"Liu KQ, Bunnell SC, Gurniak CB, Berg LJ (1998) T cell receptor-initiated calcium release is uncoupled from capacitative calcium entry in Itk-deficient T cells. J Exp Med 187(10):1721\u20131727","journal-title":"J Exp Med"},{"issue":"16","key":"1958_CR31","doi-asserted-by":"crossref","first-page":"8440","DOI":"10.1074\/jbc.M115.713008","volume":"291","author":"X Liu","year":"2016","unstructured":"Liu X, Berry CT, Ruthel G, Madara JJ, MacGillivray K, Gray CM, Madge LA, McCorkell KA, Beiting DP, Hershberg U, May MJ, Freedman BD (2016) T cell receptor-induced nuclear factor kappaB (NF-kappaB) signaling and transcriptional activation are regulated by STIM1- and Orai1-mediated calcium entry. J Biol Chem 291(16):8440\u20138452","journal-title":"J Biol Chem"},{"issue":"6","key":"1958_CR32","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/1074-7613(95)90065-9","volume":"3","author":"XC Liao","year":"1995","unstructured":"Liao XC, Littman DR (1995) Altered T cell receptor signaling and disrupted T cell development in mice lacking Itk. Immunity 3(6):757\u2013769","journal-title":"Immunity"},{"issue":"12","key":"1958_CR33","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1111\/j.1742-4658.2011.08073.x","volume":"278","author":"W Ellmeier","year":"2011","unstructured":"Ellmeier W, Abramova A, Schebesta A (2011) Tec family kinases: regulation of FcepsilonRI-mediated mast-cell activation. FEBS J 278(12):1990\u20132000","journal-title":"FEBS J"},{"issue":"8","key":"1958_CR34","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2174\/156802609789044443","volume":"9","author":"N Sahu","year":"2009","unstructured":"Sahu N, August A (2009) ITK inhibitors in inflammation and immune-mediated disorders. Curr Top Med Chem 9(8):690\u2013703","journal-title":"Curr Top Med Chem"},{"issue":"4","key":"1958_CR35","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.jaci.2005.12.1330","volume":"117","author":"TJ Ferrara","year":"2006","unstructured":"Ferrara TJ, Mueller C, Sahu N, Ben-Jebria A, August A (2006) Reduced airway hyperresponsiveness and tracheal responses during allergic asthma in mice lacking tyrosine kinase inducible T-cell kinase. J Allergy Clin Immunol 117(4):780\u2013786","journal-title":"J Allergy Clin Immunol"},{"issue":"10","key":"1958_CR36","doi-asserted-by":"crossref","first-page":"5056","DOI":"10.4049\/jimmunol.170.10.5056","volume":"170","author":"C Mueller","year":"2003","unstructured":"Mueller C, August A (2003) Attenuation of immunological symptoms of allergic asthma in mice lacking the tyrosine kinase ITK. J Immunol 170(10):5056\u20135063","journal-title":"J Immunol"},{"issue":"6","key":"1958_CR37","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.4049\/jimmunol.180.6.3833","volume":"180","author":"N Sahu","year":"2008","unstructured":"Sahu N, Mueller C, Fischer A, August A (2008) Differential sensitivity to Itk kinase signals for T helper 2 cytokine production and chemokine-mediated migration. J Immunol 180(6):3833\u20133838","journal-title":"J Immunol"},{"issue":"9","key":"1958_CR38","doi-asserted-by":"crossref","first-page":"6125","DOI":"10.4049\/jimmunol.181.9.6125","volume":"181","author":"N Sahu","year":"2008","unstructured":"Sahu N, Venegas AM, Jankovic D, Mitzner W, Gomez-Rodriguez J, Cannons JL, Sommers C, Love P, Sher A, Schwartzberg PL, August A (2008) Selective expression rather than specific function of Txk and Itk regulate Th1 and Th2 responses. J Immunol 181(9):6125\u20136131","journal-title":"J Immunol"},{"issue":"1","key":"1958_CR39","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1523\/JNEUROSCI.1957-14.2015","volume":"35","author":"AK Kannan","year":"2015","unstructured":"Kannan AK, Kim DG, August A, Bynoe MS (2015) Itk signals promote neuroinflammation by regulating CD4+ T-cell activation and trafficking. J Neurosci 35(1):221\u2013233","journal-title":"J Neurosci"},{"issue":"4","key":"1958_CR40","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jaci.2013.04.033","volume":"132","author":"AK Kannan","year":"2013","unstructured":"Kannan AK, Sahu N, Mohanan S, Mohinta S, August A (2013) IL-2-inducible T-cell kinase modulates TH2-mediated allergic airway inflammation by suppressing IFN-gamma in naive CD4+ T cells. J Allergy Clin Immunol 132(4):811\u2013820 e811-815","journal-title":"J Allergy Clin Immunol"},{"issue":"405","key":"1958_CR41","doi-asserted-by":"crossref","first-page":"ra122","DOI":"10.1126\/scisignal.aab0949","volume":"8","author":"Y Sun","year":"2015","unstructured":"Sun Y, Peng I, Webster JD et al (2015) Inhibition of the kinase ITK in a mouse model of asthma reduces cell death and fails to inhibit the inflammatory response. Sci Signal 8(405):ra122","journal-title":"Sci Signal"},{"issue":"4","key":"1958_CR42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000067589","volume":"129","author":"Y Matsumoto","year":"2002","unstructured":"Matsumoto Y, Oshida T, Obayashi I, Imai Y, Matsui K, Yoshida NL, Nagata N, Ogawa K, Obayashi M, Kashiwabara T, Gunji S, Nagasu T, Sugita Y, Tanaka T, Tsujimoto G, Katsunuma T, Akasawa A, Saito H (2002) Identification of highly expressed genes in peripheral blood T cells from patients with atopic dermatitis. Int Arch Allergy Immunol 129(4):327\u2013340","journal-title":"Int Arch Allergy Immunol"},{"issue":"1","key":"1958_CR43","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-0625.2010.01198.x","volume":"20","author":"A von Bonin","year":"2011","unstructured":"von Bonin A, Rausch A, Mengel A, Hitchcock M, Kr\u00fcger M, von Ahsen O, Merz C, R\u00f6se L, Stock C, Martin SF, Leder G, D\u00f6cke WD, Asadullah K, Z\u00fcgel U (2011) Inhibition of the IL-2-inducible tyrosine kinase (Itk) activity: a new concept for the therapy of inflammatory skin diseases. Exp Dermatol 20(1):41\u201347","journal-title":"Exp Dermatol"},{"issue":"7","key":"1958_CR44","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-136-7-200204020-00011","volume":"136","author":"NS Young","year":"2002","unstructured":"Young NS (2002) Acquired aplastic anemia. Ann Intern Med 136(7):534\u2013546","journal-title":"Ann Intern Med"},{"issue":"19","key":"1958_CR45","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1056\/NEJM199705083361906","volume":"336","author":"NS Young","year":"1997","unstructured":"Young NS, Maciejewski J (1997) The pathophysiology of acquired aplastic anemia. N Engl J Med 336(19):1365\u20131372","journal-title":"N Engl J Med"},{"issue":"5708","key":"1958_CR46","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1126\/science.1103336","volume":"307","author":"ES Hwang","year":"2005","unstructured":"Hwang ES, Szabo SJ, Schwartzberg PL, Glimcher LH (2005) T helper cell fate specified by kinase-mediated interaction of T-bet with GATA-3. Science 307(5708):430\u2013433","journal-title":"Science"},{"issue":"10","key":"1958_CR47","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1182\/blood-2005-10-4201","volume":"107","author":"EE Solomou","year":"2006","unstructured":"Solomou EE, Keyvanfar K, Young NS (2006) T-bet, a Th1 transcription factor, is up-regulated in T cells from patients with aplastic anemia. Blood 107(10):3983\u20133991","journal-title":"Blood"},{"issue":"10","key":"1958_CR48","doi-asserted-by":"crossref","first-page":"4822","DOI":"10.4049\/jimmunol.1501828","volume":"195","author":"HS Cho","year":"2015","unstructured":"Cho HS, Shin HM, Haberstock-Debic H, Xing Y, Owens TD, Funk JO, Hill RJ, Bradshaw JM, Berg LJ (2015) A small molecule inhibitor of ITK and RLK impairs Th1 differentiation and prevents colitis disease progression. J Immunol 195(10):4822\u20134831","journal-title":"J Immunol"},{"issue":"5","key":"1958_CR49","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1172\/JCI37901","volume":"119","author":"K Huck","year":"2009","unstructured":"Huck K, Feyen O, Niehues T, R\u00fcschendorf F, H\u00fcbner N, Laws HJ, Telieps T, Knapp S, Wacker HH, Meindl A, Jumaa H, Borkhardt A (2009) Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation. J Clin Invest 119(5):1350\u20131358","journal-title":"J Clin Invest"},{"issue":"5","key":"1958_CR50","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/bjh.12422","volume":"162","author":"N Parvaneh","year":"2013","unstructured":"Parvaneh N, Filipovich AH, Borkhardt A (2013) Primary immunodeficiencies predisposed to Epstein-Barr virus-driven haematological diseases. Br J Haematol 162(5):573\u2013586","journal-title":"Br J Haematol"},{"issue":"2","key":"1958_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1084\/jem.20161846","volume":"214","author":"SG Tangye","year":"2017","unstructured":"Tangye SG, Palendira U, Edwards ES (2017) Human immunity against EBV-lessons from the clinic. J Exp Med 214(2):269\u2013283","journal-title":"J Exp Med"},{"key":"1958_CR52","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3389\/fimmu.2018.00979","volume":"9","author":"S Ghosh","year":"2018","unstructured":"Ghosh S, Drexler I, Bhatia S, Adler H, Gennery AR, Borkhardt A (2018) Interleukin-2-inducible T-cell kinase deficiency-new patients, new insight? Front Immunol 9:979","journal-title":"Front Immunol"},{"issue":"5","key":"1958_CR53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/leu.2011.371","volume":"26","author":"RM Linka","year":"2012","unstructured":"Linka RM, Risse SL, Bienemann K, Werner M, Linka Y, Krux F, Synaeve C, Deenen R, Ginzel S, Dvorsky R, Gombert M, Halenius A, Hartig R, Helminen M, Fischer A, Stepensky P, Vettenranta K, K\u00f6hrer K, Ahmadian MR, Laws HJ, Fleckenstein B, Jumaa H, Latour S, Schraven B, Borkhardt A (2012) Loss-of-function mutations within the IL-2 inducible kinase ITK in patients with EBV-associated lymphoproliferative diseases. Leukemia 26(5):963\u2013971","journal-title":"Leukemia"},{"issue":"4","key":"1958_CR54","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10875-019-00632-5","volume":"39","author":"A Eken","year":"2019","unstructured":"Eken A, Cansever M, Somekh I, Mizoguchi Y, Zietara N, Okus FZ, Erdem S, Canatan H, Akyol S, Ozcan A, Karakukcu M, Hollizeck S, Rohlfs M, Unal E, Klein C, Patiroglu T (2019) Genetic deficiency and biochemical inhibition of ITK affect human Th17, Treg, and innate lymphoid cells. J Clin Immunol 39(4):391\u2013400","journal-title":"J Clin Immunol"},{"issue":"11","key":"1958_CR55","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1093\/cid\/ciy942","volume":"68","author":"L Youssefian","year":"2019","unstructured":"Youssefian L, Vahidnezhad H, Yousefi M, Saeidian AH, Azizpour A, Touati A, Nikbakht N, Hesari KK, Adib-Sereshki MM, Zeinali S, Mansoori B, Jazayeri A, Karamzadeh R, Fortina P, Jouanguy E, Casanova JL, Uitto J (2019) Inherited interleukin 2-inducible T-cell (ITK) kinase deficiency in siblings with Epidermodysplasia Verruciformis and Hodgkin lymphoma. Clin Infect Dis 68(11):1938\u20131941","journal-title":"Clin Infect Dis"},{"issue":"7","key":"1958_CR56","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.1601202","volume":"198","author":"SM Kapnick","year":"2017","unstructured":"Kapnick SM, Stinchcombe JC, Griffiths GM, Schwartzberg PL (2017) Inducible T cell kinase regulates the acquisition of cytolytic capacity and degranulation in CD8(+) CTLs. J Immunol 198(7):2699\u20132711","journal-title":"J Immunol"},{"key":"1958_CR57","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12935-019-0754-9","volume":"19","author":"Y Liu","year":"2019","unstructured":"Liu Y, Wang X, Deng L, Ping L, Shi Y, Zheng W, Lin N, Wang X, Tu M, Xie Y, Liu W, Ying Z, Zhang C, Pan Z, Wang X, Ding N, Song Y, Zhu J (2019) ITK inhibition induced in vitro and in vivo anti-tumor activity through downregulating TCR signaling pathway in malignant T cell lymphoma. Cancer Cell Int 19:32","journal-title":"Cancer Cell Int"},{"issue":"2","key":"1958_CR58","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1200\/JCO.2011.37.3647","volume":"31","author":"M Federico","year":"2013","unstructured":"Federico M, Rudiger T, Bellei M, Nathwani BN, Luminari S, Coiffier B, Harris NL, Jaffe ES, Pileri SA, Savage KJ, Weisenburger DD, Armitage JO, Mounier N, Vose JM (2013) Clinicopathologic characteristics of angioimmunoblastic T-cell lymphoma: analysis of the international peripheral T-cell lymphoma project. J Clin Oncol 31(2):240\u2013246","journal-title":"J Clin Oncol"},{"issue":"1","key":"1958_CR59","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T Rudiger","year":"2002","unstructured":"Rudiger T, Weisenburger DD, Anderson JR et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin\u2019s Lymphoma Classification Project. Ann Oncol 13(1):140\u2013149","journal-title":"Ann Oncol"},{"issue":"25","key":"1958_CR60","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","volume":"26","author":"J Vose","year":"2008","unstructured":"Vose J, Armitage J, Weisenburger D, International TCLP (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130","journal-title":"J Clin Oncol"},{"issue":"9","key":"1958_CR61","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/blood-2007-08-105759","volume":"111","author":"N Mourad","year":"2008","unstructured":"Mourad N, Mounier N, Briere J et al (2008) Clinical, biologic, and pathologic features in 157 patients with angioimmunoblastic T-cell lymphoma treated within the Groupe d\u2019Etude des Lymphomes de l'Adulte (GELA) trials. Blood 111(9):4463\u20134470","journal-title":"Blood"},{"issue":"10","key":"1958_CR62","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1097\/PAS.0000000000000309","volume":"38","author":"C Agostinelli","year":"2014","unstructured":"Agostinelli C, Rizvi H, Paterson J, Shende V, Akarca AU, Agostini E, Fuligni F, Righi S, Spagnolo S, Piccaluga PP, Clark EA, Pileri SA, Marafioti T (2014) Intracellular TCR-signaling pathway: novel markers for lymphoma diagnosis and potential therapeutic targets. Am J Surg Pathol 38(10):1349\u20131359","journal-title":"Am J Surg Pathol"},{"issue":"5","key":"1958_CR63","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1084\/jem.20092042","volume":"207","author":"K Pechloff","year":"2010","unstructured":"Pechloff K, Holch J, Ferch U, Schweneker M, Brunner K, Kremer M, Sparwasser T, Quintanilla-Martinez L, Zimber-Strobl U, Streubel B, Gewies A, Peschel C, Ruland J (2010) The fusion kinase ITK-SYK mimics a T cell receptor signal and drives oncogenesis in conditional mouse models of peripheral T cell lymphoma. J Exp Med 207(5):1031\u20131044","journal-title":"J Exp Med"},{"issue":"9","key":"1958_CR64","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/1078-0432.CCR-14-1826","volume":"21","author":"CC Carson","year":"2015","unstructured":"Carson CC, Moschos SJ, Edmiston SN, Darr DB, Nikolaishvili-Feinberg N, Groben PA, Zhou X, Kuan PF, Pandey S, Chan KT, Jordan JL, Hao H, Frank JS, Hopkinson DA, Gibbs DC, Alldredge VD, Parrish E, Hanna SC, Berkowitz P, Rubenstein DS, Miller CR, Bear JE, Ollila DW, Sharpless NE, Conway K, Thomas NE (2015) IL2 inducible T-cell kinase, a novel therapeutic target in melanoma. Clin Cancer Res 21(9):2167\u20132176","journal-title":"Clin Cancer Res"},{"issue":"8","key":"1958_CR65","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.4049\/jimmunol.1102475","volume":"188","author":"Q Qi","year":"2012","unstructured":"Qi Q, Huang W, Bai Y, Balmus G, Weiss RS, August A (2012) A unique role for ITK in survival of invariant NKT cells associated with the p53-dependent pathway in mice. J Immunol 188(8):3611\u20133619","journal-title":"J Immunol"},{"issue":"34","key":"1958_CR66","doi-asserted-by":"crossref","first-page":"11056","DOI":"10.1021\/bi049428r","volume":"43","author":"TA Lin","year":"2004","unstructured":"Lin TA, McIntyre KW, Das J et al (2004) Selective Itk inhibitors block T-cell activation and murine lung inflammation. Biochemistry 43(34):11056\u201311062","journal-title":"Biochemistry"},{"issue":"14","key":"1958_CR67","doi-asserted-by":"crossref","first-page":"3706","DOI":"10.1016\/j.bmcl.2006.04.060","volume":"16","author":"J Das","year":"2006","unstructured":"Das J, Furch JA, Liu C, Moquin RV, Lin J, Spergel SH, McIntyre KW, Shuster DJ, O\u2019Day KD, Penhallow B, Hung CY, Doweyko AM, Kamath A, Zhang H, Marathe P, Kanner SB, Lin TA, Dodd JH, Barrish JC, Wityak J (2006) Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Bioorg Med Chem Lett 16(14):3706\u20133712","journal-title":"Bioorg Med Chem Lett"},{"issue":"1","key":"1958_CR68","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1087057106296047","volume":"12","author":"MA Kashem","year":"2007","unstructured":"Kashem MA, Nelson RM, Yingling JD, Pullen SS, Prokopowicz AS III, Jones JW, Wolak JP, Rogers GR, Morelock MM, Snow RJ, Homon CA, Jakes S (2007) Three mechanistically distinct kinase assays compared: measurement of intrinsic ATPase activity identified the most comprehensive set of ITK inhibitors. J Biomol Screen 12(1):70\u201383","journal-title":"J Biomol Screen"},{"issue":"13","key":"1958_CR69","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1016\/j.bmcl.2007.04.045","volume":"17","author":"RJ Snow","year":"2007","unstructured":"Snow RJ, Abeywardane A, Campbell S, Lord J, Kashem MA, Khine HH, King J, Kowalski JA, Pullen SS, Roma T, Roth GP, Sarko CR, Wilson NS, Winters MP, Wolak JP, Cywin CL (2007) Hit-to-lead studies on benzimidazole inhibitors of ITK: discovery of a novel class of kinase inhibitors. Bioorg Med Chem Lett 17(13):3660\u20133665","journal-title":"Bioorg Med Chem Lett"},{"issue":"2","key":"1958_CR70","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/sji.12069","volume":"78","author":"L Vargas","year":"2013","unstructured":"Vargas L, Hamasy A, Nore BF, Smith CI (2013) Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases. Scand J Immunol 78(2):130\u2013139","journal-title":"Scand J Immunol"},{"issue":"4","key":"1958_CR71","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1517\/13543771003674409","volume":"20","author":"HY Lo","year":"2010","unstructured":"Lo HY (2010) Itk inhibitors: a patent review. Expert Opin Ther Pat 20(4):459\u2013469","journal-title":"Expert Opin Ther Pat"},{"issue":"15","key":"1958_CR72","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.1182\/blood-2013-06-507947","volume":"122","author":"JA Dubovsky","year":"2013","unstructured":"Dubovsky JA, Beckwith KA, Natarajan G, Woyach JA, Jaglowski S, Zhong Y, Hessler JD, Liu TM, Chang BY, Larkin KM, Stefanovski MR, Chappell DL, Frissora FW, Smith LL, Smucker KA, Flynn JM, Jones JA, Andritsos LA, Maddocks K, Lehman AM, Furman R, Sharman J, Mishra A, Caligiuri MA, Satoskar AR, Buggy JJ, Muthusamy N, Johnson AJ, Byrd JC (2013) Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes. Blood 122(15):2539\u20132549","journal-title":"Blood"},{"issue":"3","key":"1958_CR73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/pro.321","volume":"19","author":"DJ Marcotte","year":"2010","unstructured":"Marcotte DJ, Liu YT, Arduini RM, Hession CA, Miatkowski K, Wildes CP, Cullen PF, Hong V, Hopkins BT, Mertsching E, Jenkins TJ, Romanowski MJ, Baker DP, Silvian LF (2010) Structures of human Bruton\u2019s tyrosine kinase in active and inactive conformations suggest a mechanism of activation for TEC family kinases. Protein Sci 19(3):429\u2013439","journal-title":"Protein Sci"},{"issue":"1","key":"1958_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11899-012-0147-9","volume":"8","author":"JR Brown","year":"2013","unstructured":"Brown JR (2013) Ibrutinib (PCI-32765), the first BTK (Bruton\u2019s tyrosine kinase) inhibitor in clinical trials. Curr Hematol Malig Rep 8(1):1\u20136","journal-title":"Curr Hematol Malig Rep"},{"issue":"9","key":"1958_CR75","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1182\/blood-2011-12-396853","volume":"120","author":"YT Tai","year":"2012","unstructured":"Tai YT, Chang BY, Kong SY, Fulciniti M, Yang G, Calle Y, Hu Y, Lin J, Zhao JJ, Cagnetta A, Cea M, Sellitto MA, Zhong MY, Wang Q, Acharya C, Carrasco DR, Buggy JJ, Elias L, Treon SP, Matsui W, Richardson P, Munshi NC, Anderson KC (2012) Bruton tyrosine kinase inhibition is a novel therapeutic strategy targeting tumor in the bone marrow microenvironment in multiple myeloma. Blood 120(9):1877\u20131887","journal-title":"Blood"},{"issue":"2","key":"1958_CR76","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s11864-013-0230-z","volume":"14","author":"LK Brett","year":"2013","unstructured":"Brett LK, Williams ME (2013) Current and emerging therapies in mantle cell lymphoma. Curr Treat Options in Oncol 14(2):198\u2013211","journal-title":"Curr Treat Options in Oncol"},{"issue":"11","key":"1958_CR77","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.3109\/10428194.2013.777837","volume":"54","author":"JA Burger","year":"2013","unstructured":"Burger JA, Buggy JJ (2013) Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765). Leuk Lymphoma 54(11):2385\u20132391","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"1958_CR78","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar3400","volume":"13","author":"BY Chang","year":"2011","unstructured":"Chang BY, Huang MM, Francesco M, Chen J, Sokolove J, Magadala P, Robinson WH, Buggy JJ (2011) The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells. Arthritis Res Ther 13(4):R115","journal-title":"Arthritis Res Ther"},{"key":"1958_CR79","doi-asserted-by":"crossref","first-page":"104441","DOI":"10.1016\/j.phrs.2019.104441","volume":"148","author":"A Nadeem","year":"2019","unstructured":"Nadeem A, Ahmad SF, Al-Harbi NO, Ibrahim KE, Siddiqui N, Al-Harbi MM, Attia SM, Bakheet SA (2019) Inhibition of Bruton's tyrosine kinase and IL-2 inducible T-cell kinase suppresses both neutrophilic and eosinophilic airway inflammation in a cockroach allergen extract-induced mixed granulocytic mouse model of asthma using preventative and therapeutic strategy. Pharmacol Res 148:104441","journal-title":"Pharmacol Res"},{"issue":"8","key":"1958_CR80","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1182\/bloodadvances.2017011916","volume":"2","author":"A Kumar","year":"2018","unstructured":"Kumar A, Vardhana S, Moskowitz AJ, Porcu P, Dogan A, Dubovsky JA, Matasar MJ, Zhang Z, Younes A, Horwitz SM (2018) Pilot trial of ibrutinib in patients with relapsed or refractory T-cell lymphoma. Blood Adv 2(8):871\u2013876","journal-title":"Blood Adv"},{"issue":"10","key":"1958_CR81","doi-asserted-by":"crossref","first-page":"5960","DOI":"10.1074\/jbc.M114.614891","volume":"290","author":"Y Zhong","year":"2015","unstructured":"Zhong Y, Dong S, Strattan E, Ren L, Butchar JP, Thornton K, Mishra A, Porcu P, Bradshaw JM, Bisconte A, Owens TD, Verner E, Brameld KA, Funk JO, Hill RJ, Johnson AJ, Dubovsky JA (2015) Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694. J Biol Chem 290(10):5960\u20135978","journal-title":"J Biol Chem"},{"issue":"4","key":"1958_CR82","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jid.2017.10.029","volume":"138","author":"JM Fuhriman","year":"2018","unstructured":"Fuhriman JM, Winge MCG, Haberstock-Debic H, Funk JO, Bradshaw JM, Marinkovich MP (2018) ITK and RLK inhibitor PRN694 improves skin disease in two mouse models of psoriasis. J Invest Dermatol 138(4):864\u2013871","journal-title":"J Invest Dermatol"},{"key":"1958_CR83","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejmech.2019.03.055","volume":"173","author":"G Tang","year":"2019","unstructured":"Tang G, Liu L, Wang X, Pan Z (2019) Discovery of 7H-pyrrolo[2,3-d]pyrimidine derivatives as selective covalent irreversible inhibitors of interleukin-2-inducible T-cell kinase (Itk). Eur J Med Chem 173:167\u2013183","journal-title":"Eur J Med Chem"},{"issue":"6","key":"1958_CR84","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1021\/acschembio.9b00188","volume":"14","author":"H Xu","year":"2019","unstructured":"Xu H, Jesson MI, Seneviratne UI, Lin TH, Sharif MN, Xue L, Nguyen C, Everley RA, Trujillo JI, Johnson DS, Point GR, Thorarensen A, Kilty I, Telliez JB (2019) PF-06651600, a dual JAK3\/TEC family kinase inhibitor. ACS Chem Biol 14(6):1235\u20131242","journal-title":"ACS Chem Biol"},{"issue":"8","key":"1958_CR85","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1177\/2472555219857542","volume":"24","author":"R Hantani","year":"2019","unstructured":"Hantani R, Hanawa S, Oie S, Umetani K, Sato T, Hantani Y (2019) Identification of a new inhibitor that stabilizes Interleukin-2-inducible T-cell kinase in its inactive conformation. SLAS Discov 24(8):854\u2013862","journal-title":"SLAS Discov"},{"issue":"3","key":"1958_CR86","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.jdermsci.2020.01.013","volume":"97","author":"H Li","year":"2020","unstructured":"Li H, Wang C, Ma P, Zhang M, Yang H, Yuan S, Wei J, Tao L, Qian K, Xu M, Li L (2020) The retinoid derivant ECPIRM selectively exhibited anti-proliferation effects in cutaneous T-cell lymphoma via ITK-mediated signaling pathway. J Dermatol Sci 97(3):208\u2013215","journal-title":"J Dermatol Sci"},{"issue":"18","key":"1958_CR87","doi-asserted-by":"crossref","first-page":"18727","DOI":"10.1074\/jbc.M400031200","volume":"279","author":"K Brown","year":"2004","unstructured":"Brown K, Long JM, Vial SC et al (2004) Crystal structures of interleukin-2 tyrosine kinase and their implications for the design of selective inhibitors. J Biol Chem 279(18):18727\u201318732","journal-title":"J Biol Chem"},{"issue":"13 Supplement","key":"1958_CR88","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1158\/1538-7445.AM2019-1313","volume":"79","author":"JWHC Janc","year":"2019","unstructured":"Janc JWHC, Ng PP, Hoston AN, Madriaga A, Dao-Pick TP, Yeung KS, Hudson R, Beausoleil A-M, Bradley E, Verner E, Thamm DH, Miller RA, Buggy JJ (2019) Abstract 1313: CPI-818: a selective inhibitor of interleukin-2-inducible T-cell kinase (ITK) that inhibits T-cell receptor signaling, promotes Th1 skewing, and achieves objective tumor responses when administered to dogs with T cell lymphomas. Am Assoc Cancer Res 79(13 Supplement):1313","journal-title":"Am Assoc Cancer Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01958-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-020-01958-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-020-01958-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,7]],"date-time":"2022-11-07T18:04:05Z","timestamp":1667844245000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-020-01958-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["1958"],"URL":"https:\/\/doi.org\/10.1007\/s00109-020-01958-z","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"29 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 August 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}